| Pan-cancer convergence to a small-cell neuroendocrine phenotype that shares susceptibilities with hematological malignancies NG Balanis, KM Sheu, FN Esedebe, SJ Patel, BA Smith, JW Park, ... Cancer cell 36 (1), 17-34. e7, 2019 | 129 | 2019 |
| A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes L Wang, BA Smith, NG Balanis, BL Tsai, K Nguyen, MW Cheng, ... Proceedings of the National Academy of Sciences 117 (1), 563-572, 2020 | 23 | 2020 |
| Methods for treating small cell neuroendocrine and related cancers TG Graeber, NG Balanis, ON Witte, F ESEDEBE, JW PARK US Patent App. 17/613,881, 2022 | 1 | 2022 |
| PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity G Varuzhanyan, CC Chen, J Freeland, T He, W Tran, K Song, L Wang, ... bioRxiv, 2024.04. 09.588489, 2024 | | 2024 |
| Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression A Jewett, S Huerta-Yepez, PC Chen, K Kaur, Y Jain, T Singh, F Esedebe, ... | | 2023 |
